Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial

NCT07245316 is registered in ClinicalTrials.gov with Jeong Eon Lee as lead sponsor.

NCT NCT07245316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07245316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial
Lead sponsor
Jeong Eon Lee
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 31, 2032
Enrollment
340 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ of the breast